Connect Biopharma to Present at the Leerink Partners Global Healthcare Conference

Rhea-AI Summary

Connect Biopharma (Nasdaq: CNTB) management will participate in a fireside chat at the Leerink Partners Global Healthcare Conference on March 10, 2026 at 8:00 a.m. ET.

A live webcast will be available via the company investor website and an archived replay will remain accessible for approximately 90 days.

Key Figures

Conference date: March 10, 2026 Presentation time: 8:00 a.m. ET Replay availability: approximately 90 days

3 metrics

Conference date March 10, 2026 Leerink Partners Global Healthcare Conference presentation

Presentation time 8:00 a.m. ET Scheduled fireside chat start time

Replay availability approximately 90 days Archived webcast available after conference

Market Reality Check

Price: $2.50 Vol: Volume 121,028 is 1.32x t...

normal vol

$2.50 Last Close

Volume Volume 121,028 is 1.32x the 20-day average of 91,897, modestly elevated ahead of a routine conference appearance. normal

Technical Shares at $2.50 are trading above the 200-day MA of $1.88, after a 1.21% daily gain.

Peers on Argus

Sector peers show mixed moves: OVID (+5.73%), IFRX (+3.38%), STTK (+3.90%), COYA...

1 Down

Sector peers show mixed moves: OVID (+5.73%), IFRX (+3.38%), STTK (+3.90%), COYA (+0.61%), while VXRT fell (-2.82%). Momentum scanner only flagged CNTX (-7.39%) with no news, suggesting today’s CNTB action looks more stock-specific than a broad biotech rotation.

Historical Context

5 past events · Latest: Feb 19 (Neutral)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Feb 19	Conference appearance	Neutral	-1.0%	Oppenheimer healthcare conference fireside chat announcement with webcast details.
Jan 12	Pipeline strategy	Positive	-1.4%	New mechanism-of-action data for rademikibart and 2026 clinical priorities.
Nov 24	Conference appearance	Neutral	-4.3%	Evercore Healthcare Conference fireside chat with webcast and 90-day replay.
Nov 12	Earnings and update	Neutral	+5.9%	Q3 2025 results, Seabreeze STAT progress, China NDA status, and cash runway.
Sep 29	Clinical data	Positive	-16.6%	ERS 2025 Phase 2b asthma data with FEV1 gains and fewer exacerbations.

Pattern Detected

Recent conference and data-related announcements often saw muted or negative next-day moves, even when underlying updates were positive, with one earnings update showing a stronger positive reaction.

Recent Company History

Over the past six months, CNTB has alternated between data, corporate, and earnings updates. Conference participation notices (Evercore, Oppenheimer) saw small declines of -4.28% and -1.02%. By contrast, detailed rademikibart datasets, including a 507 mL FEV1 improvement and exacerbation reductions of 63% and 69%, led to a sharper -16.64% reaction. A Q3 2025 earnings update, with cash of $54.8M and up to $110M in potential milestones, coincided with a +5.92% move. Today’s conference appearance fits the recurring pattern of non-fundamental visibility events.

Market Pulse Summary

This announcement highlights CNTB management’s participation in a Leerink Partners conference on Mar...

Analysis

This announcement highlights CNTB management’s participation in a Leerink Partners conference on March 10, 2026, with an 8:00 a.m. ET fireside chat and a webcast replay for about 90 days. It adds investor visibility but no new clinical or financial data. Recent history shows more substantial price moves tied to rademikibart trial readouts and earnings updates, so upcoming clinical milestones and liquidity trends remain important focal points when assessing future developments.

AI-generated analysis. Not financial advice.

SAN DIEGO, March 03, 2026 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma”, “Connect”, or the “Company”), a clinical-stage biopharmaceutical company focused on transforming care for the treatment of inflammatory diseases, today announced that Company management will participate in a fireside chat at the Leerink Partners Global Healthcare Conference on Tuesday, March 10, 2026 at 8:00 a.m. ET.

The live webcast of the presentation may be accessed via the Investors section of the Connect website at investors.connectbiopharma.com. An archived replay of the event will be available on the website for approximately 90 days following the conference.

About Connect Biopharma
Connect Biopharma is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and COPD. Headquartered in San Diego, California, the Company is advancing rademikibart, a next-generation, potentially best-in-class antibody designed to target IL-4Rα. The Company is currently conducting global clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD, areas with significant unmet need. Connect has granted an exclusive license to Simcere Pharmaceutical Co., Ltd., for rademikibart in Greater China. Under the exclusive license and collaboration agreement, Connect is eligible to receive remaining milestone payments up to an aggregate amount of approximately $110 million upon the achievement of certain development, regulatory and commercial milestones. Connect is also eligible to receive royalties at tiered percentage rates up to low double-digit percentages on net sales in Greater China.

For more information visit www.connectbiopharma.com.

Investor Relations Contact:
Alex Lobo
Precision AQ
Alex.lobo@precisionaq.com
(212) 698-8802

Media Contact:
Ignacio Guerrero-Ros, Ph.D., or David Schull
Russo Partners, LLC
Ignacio.guerrero-ros@russopartnersllc.com
David.schull@russopartnersllc.com
(858) 717-2310 or (646) 942-5604

FAQ

When will Connect Biopharma (CNTB) present at the Leerink Partners Global Healthcare Conference?

Connect Biopharma will present on March 10, 2026 at 8:00 a.m. ET in a scheduled fireside chat. According to the company, management will discuss recent developments and participate in a live webcast accessible through the investor website for attendees and online viewers.

How can investors watch the Connect Biopharma (CNTB) presentation on March 10, 2026?

Investors can watch the live webcast via the company investor website at investors.connectbiopharma.com. According to the company, the presentation will be streamed live and accessible directly from the Investors section for real-time viewing.

Will Connect Biopharma (CNTB) make a replay of the Leerink presentation available?

Yes, an archived replay will be available after the live event for approximately 90 days. According to the company, the replay will be posted on the investor website and remain accessible for about three months following the conference.

What topics will Connect Biopharma (CNTB) management cover at the March 10, 2026 fireside chat?

Management will participate in a fireside chat covering company developments and strategy during the conference presentation. According to the company, the discussion is intended to update investors on clinical programs and corporate progress without offering new guidance.

Where is the Leerink Partners Global Healthcare Conference presentation location for Connect Biopharma (CNTB)?

The presentation will take place at the Leerink Partners Global Healthcare Conference on March 10, 2026 at 8:00 a.m. ET and will be webcast online. According to the company, the live webcast is available through the Investors section of its website.